Page last updated: 2024-11-03

pf 5901 and Endophthalmitis

pf 5901 has been researched along with Endophthalmitis in 2 studies

alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: structure given in first source; platelet activating factor antagonist

Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.

Research Excerpts

ExcerptRelevanceReference
"When indomethacin and REV 5901 were combined, both PGE2 and PGF2 alpha were suppressed at 2 and 4 h in both iris and ciliary body."1.28Prevention of ocular inflammation by matrine, prednisolone, and cyclooxygenase and lipoxygenase inhibitors. ( Chang, MS; Chiou, GC; Xiao, JG, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, MS1
Xiao, JG1
Chiou, GC2
Chiou, LY1

Other Studies

2 other studies available for pf 5901 and Endophthalmitis

ArticleYear
Prevention of ocular inflammation by matrine, prednisolone, and cyclooxygenase and lipoxygenase inhibitors.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1991, Volume: 12, Issue:2

    Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Dinoprost; Dinop

1991
Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit.
    Journal of ocular pharmacology, 1985,Winter, Volume: 1, Issue:4

    Topics: Animals; Endophthalmitis; Female; Hydroxyquinolines; Infusions, Intravenous; Intraocular Pressure; L

1985